Clinical Trials Browser

Phase 1 × Advanced Solid Tumors × eribulin × Clear all

NCT00908908 2012-03-09

A Study to Determine the Metabolism and Elimination of Carbon-14 Labeled Eribulin Acetate (14C-Eribulin) in Patients With Advanced Solid Tumors

Phase 1 Completed

6 enrolled 7 charts

Other solid neoplasm

Advanced Solid Tumors